Source: Arranta Bio Blog

Arranta Bio Blog Join Us! Tides USA - Oligonucleotide & Peptide Therapeutics | May 7-10, 2023 | San Diego, USA

We are excited to be exhibiting at Tides USA, taking place May 7-10, 2023 in San Diego, USA. Arranta and Vibalogics offer CDMO capabilities from preclinical to clinical and commercial approval for new biological modalities. Encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production. Come [...]The post Join Us! Tides USA - Oligonucleotide & Peptide Therapeutics | May 7-10, 2023 | San Diego, USA appeared first on ArrantaBio.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Mark Bamforth's photo - Founder & CEO of Arranta Bio

Founder & CEO

Mark Bamforth

CEO Approval Rating

84/100

Read more